Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1β

American Journal of Respiratory Cell and Molecular Biology

Volumn 31, Issue 3, 2004, Pages 283-291

  Lee, Steven A ^b   Fitzgerald, S Matthew ^b   Huang, Shau K ^b   Li, Chuanfu ^b   Chi, David S ^b   Milhorn, Denise M ^b   Krishnaswamy, Guha ^a  

^a East Tennessee State University   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN RECEPTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTHMA; CELL NUCLEUS; CYTOKINE PRODUCTION; DOSE RESPONSE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNITY; INFLAMMATION; MAST CELL; MONOCYTE; PROTEIN EXPRESSION; RECEPTOR BINDING; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE; CHEMOKINE CCL2; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-13; MAST CELLS; NF-KAPPA B; PROTEIN KINASES; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE I; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4444358455     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2004-0089OC     Document Type: Article

References (32)

1. Krishnaswamy, G., J. Kelley, D. Johnson, G. Youngberg, W. Stone, S. K. Huang, J. Bieber, and D. S. Chi. 2001. The human mast cell: functions in physiology and disease. Front. Biosci. 6:D1109-D1127.
2. Burd, P. R., W. C. Thompson, E. E. Max, and F. C. Mills. 1995. Activated mast cells produce interleukin 13. J. Exp. Med. 181:1373-1380.
3. Zurawski, G., and J. E. de Vries. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19-26.
4. Borish, L. C., and J. W. Steinke. 2003. Cytokines and chemokines. J. Allergy Clin. Immunol. 111:S460-S475.
5. Grunig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261-2263.
6. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258-2261.
7. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103:779-788.
8. Rose, C. E., Jr., S. S. Sung, and S. M. Fu. 2003. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10:273-288.
9. Campbell, E. M., I. F. Charo, S. L. Kunkel, R. M. Strieter, L. Boring, J. Gosling, and N. W. Lukacs. 1999. Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells. J. Immunol. 163:2160-2167.
10. McMahan, C. J., J. L. Slack, B. Mosley, D. Cosman, S. D. Lupton, L. L. Brunton, C. E. Grubín, J. M. Wignall, N. A. Jenkins, and C. I. Brannan. 1991. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10:2821-2832.
11. Stylianou, E., L. A. O'Neill, L. Rawlinson, M. R. Edbrooke, P. Woo, and J. Saklatvala. 1992. Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. J. Biol. Chem. 267:15836-15841.
12. Haskill, S., G. Martin, L. Van Le, J. Morris, A. Peace, C. F. Bigler, G. J. Jaffe, C. Hammerberg, S. A. Sporn, and S. Fong. 1991. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc. Natl. Acad. Sci. U.S.A. 88:3681-3685.
13. Auron, P. E. 1998. The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev. 9:221-237.
14. Martin, M. U., and H. Wesche. 2002. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim. Biophys. Acta 1592:265-280.
15. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095-2147.
16. Hultner, L., S. Kolsch, M. Stassen, U. Kaspers, J. P. Kremer, R. Mailhammer, J. Moeller, H. Broszeit, and E. Schmitt. 2000. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J. Immunol. 164:5556-5563.
17. Lu-Kuo, J. M., K. F. Austen, and H. R. Katz. 1996. Post-transcriptional stabilization by interleukin-1beta of interleukin-6 mRNA induced by c-kit ligand and interleukin-10 in mouse bone marrow-derived mast cells. J. Biol. Chem. 271:22169-22174.
18. Hogaboam, C. M., A. D. Befus, and J. L. Wallace. 1993. Modulation of rat mast cell reactivity by IL-1 beta: divergent effects on nitric oxide and platelet-activating factor release. J. Immunol. 151:3767-3774.
19. Krishnaswamy, G., K. Hall, G. Youngberg, F. Hossler, D. Johnson, W. A. Block, S. K. Huang, J. Kelley, and D. S. Chi. 2002. Regulation of eosinophilactive cytokine production from human cord blood-derived mast cells. J. Interferon Cytokine Res. 22:379-388.
20. Krishnaswamy, G., J. Kelley, L. Yerra, J. K. Smith, and D. S. Chi. 1999. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J. Interferon Cytokine Res. 19:91-104.
21. Krishnaswamy, G., J. K. Smith, R. Mukkamala, K. Hall, W. Joyner, L. Yerra, and D. S. Chi. 1998. Multifunctional cytokine expression by human coronary endothelium and regulation by monokines and glucocorticoids. Microvasc. Res. 55:189-200.
22. Essayan, D. M., G. Krishnaswamy, and S. K. Huang. 1997. Immunologic investigations of T-cell regulation of human IgE antibody secretion and allergic responses. Methods 13:69-78.
23. Li, C., W. Browder, and R. L. Kao. 1999. Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart. Am. J. Physiol. 276:H543-H552.
24. Borish, L., and L. J. Rosenwasser. 1996. Update on cytokines. J. Allergy Clin. Immunol. 97:719-733.
25. Dinarello, C. A. 2000. Proinflammatory cytokines. Chest 118:503-508.
26. Krishnaswamy, G., R. Martin, E. Walker, C. Li, F. Hossler, K. Hall, and D. S. Chi. 2003. Moraxella catarrhalis induces mast cell activation and nuclear factor kappaB-dependent cytokine synthesis. Front. Biosci. 8:A40-A47.
27. Pierce, J. W., R. Schoenleber, G. Jesmok, J. Best, S. A. Moore, T. Collins, and M. E. Gerritsen. 1997. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272:21096-21103.
28. Pype, J. L., L. J. Dupont, P. Menten, E. Van Coillie, G. Opdenakker, J. Van Damme, K. F. Chung, M. G. Demedts, and G. M. Verleden. 1999. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells: modulation by corticosteroids and T-helper 2 cytokines. Am. J. Respir. Cell Mol. Biol. 21:528-536.
29. Fushimi, T., S. Shimura, S. Suzuki, H. Saitoh, H. Okayama, and K. Shirato. 1998. Suppression of gene expression and production of interleukin 13 by dexamethasone in human peripheral blood mononuclear cells. Tohoku J. Exp. Med. 185:157-160.
30. Varadaradjalou, S., F. Feger, N. Thieblemont, N. B. Hamouda, J. M. Pleau, M. Dy, and M. Arock. 2003. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 33:899-906.
31. Okumura, S., J. Kashiwakura, H. Tomita, K. Matsumoto, T. Nakajima, H. Saito, and Y. Okayama. 2003. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. Blood 102:2547-2554.
32. Yoshikawa, H., and K. Tasaka. 2003. Caspase-dependent and -independent apoptosis of mast cells induced by withdrawal of IL-3 is prevented by Toll-like receptor 4-mediated lipopolysaccharide stimulation. Eur. J. Immunol. 33:2149-2159.